Comparison of cisatracurium versus atracurium in early ards

Respiratory Care

Volumn 62, Issue 7, 2017, Pages 947-952

  Moore, Leanne ^a   Kramer, Charles Joseph ^a   Delcoix Lopes, Sophie ^a   Modrykamien, Ariel M ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ARDS; Mechanical ventilation; Neuromuscular blockers; Oxygenation

Indexed keywords

ATRACURIUM BESILATE; CISATRACURIUM; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY PRESSURE; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BODY MASS; BRAIN FUNCTION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE UNIT; INTERSTITIAL LUNG DISEASE; LENGTH OF STAY; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXYGENATION; PANCREATITIS; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; TREATMENT DURATION; VIRUS PNEUMONIA; AGED; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; DRUG EFFECTS; MORTALITY; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; AGED; ATRACURIUM; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; OXYGEN CONSUMPTION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85028805258     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.05102     Document Type: Article

References (21)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-824.
2. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012; 38(10):1573-1582.
3. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301-1308.
4. Guerin C, Reignier J, Richard JC. Prone positioning in the acute respiratory distress syndrome. N Engl J Med 2013;369(10):980-981.
5. Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010;303(9):865-873.
6. Putensen C, Zech S, Wrigge H, Zinserling J, Stüber F, Von Spiegel T, Mutz, N. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 2001;164(1):43-9.
7. Peek GJ, Clemens F, Elbourne D, Firmin R, Hardy P, Hibbert C, et al. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res 2006;6:163.
8. Adhikari NK, Burns KE, Friedrich JO, Granton JT, Cook DJ, Meade MO. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ 2007; 334(7597):779.
9. Meduri GU, Marik PE, Chrousos GP, Pastores SM, Arlt W, Beishuizen A, et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 2008;34(1):61-69.
10. Stenlake JB, Waigh RD, Urwin J, Dewar GH, Coker GG. Atracurium: conception and inception. Br J Anaesth. 1983;55(Suppl 1):3S– 10S.
11. Dear GJ, Harrelson JC, Jones AE, Johnson TE, Pleasance S. Identification of urinary and biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography/mass spec-trometry. Rapid Commun Mass Spectrom 1995;9(14):1457-1464.
12. Fodale V, Santamaria LB. Laudanosine, an atracurium and cisatracurium metabolite. Eur J Anaesthesiol 2002;19(7):466-473.
13. Savarese JJ, Wastila WB. The future of the benzylisoquinolinium relaxants. Acta Anaesthesiol Scand Suppl 1995;106:91-93.
14. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loun-dou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363(12):1107-1116.
15. Patki A, Shelgaonkar VC. A comparison of equisedative infusions of propofol and midazolam for conscious sedation during spinal anesthesia: a prospective randomized study. J Anaesthesiol Clin Pharmacol 2011;27(1):47-53.
16. Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit: executive summary. Am J Health Syst Pharm 2013;70(1):53-58.
17. Bishop MJ. Hemodynamic and gas exchange effects of pancuronium bromide in sedated patients with respiratory failure. Anesthesiology 1984;60(4):369-371.
18. Coggeshall JW, Marini JJ, Newman JH. Improved oxygenation after muscle relaxation in adult respiratory distress syndrome. Arch Intern Med 1985;145(9):1718-1720.
19. Conti G, Vilardi V, Rocco M, DeBlasi RA, Lappa A, Bufi M, et al. Paralysis has no effect on chest wall and respiratory system mechanics of mechanically ventilated, sedated patients. Intensive Care Med 1995;21(10):808-812.
20. Gainnier M, Roch A, Forel JM, Thirion X, Arnal JM, Donati S, Papazian L. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004;32(1):113-119.
21. Forel JM, Roch A, Marin V, Michelet P, Demory D, Blache JL, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006;34(11):2749-2757.